PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Clinical Lung Cancer - Tập 22 - Trang 423-431 - 2021
Filippo G. Dall'Olio1, Francesco Gelsomino1, Nicole Conci1, Laura Marcolin2, Andrea De Giglio1, Giada Grilli1, Francesca Sperandi1, Francesca Fontana3, Mario Terracciano3, Benedetta Fragomeno1, Nastassja Tober1, Giulia Manferrari4, Stefano Brocchi2, Rita Golfieri2, Michelangelo Fiorentino5, Andrea Ardizzoni1
1Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
2Department of Radiology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy
3Menarini Silicon Biosystems Spa, Bologna, Italy
4Department of Genetics, Environment, and Evolution (GEE), University College London, London, United Kingdom
5Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy

Thông tin
Thông tin xuất bản

Clinical Lung Cancer

Tập 22

423-431

Thông tin tác giả